{"id":205873,"date":"2026-08-17T10:22:33","date_gmt":"2026-08-17T04:52:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=205873"},"modified":"2026-08-17T10:22:33","modified_gmt":"2026-08-17T04:52:33","slug":"why-morepen-laboratories-ltd-share-price-52-week-high-2026-08-17","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-morepen-laboratories-ltd-share-price-52-week-high-2026-08-17\/","title":{"rendered":"Morepen Laboratories Ltd. (MOREPENLAB) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\">Morepen Laboratories Ltd.<\/a> Share Price rose to Rs 85.22, up 1.19% today, after hitting a fresh 52-week high of Rs 86.88. Market capitalisation stands at Rs 4,614.87 crore.<\/p>\n<p style=\"margin-top:0!important;\">Morepen Laboratories Ltd. Share Price was at Rs 85.22 on 17 August 2026, up 1.19% from the previous close of Rs 84.22, after the stock touched a fresh 52-week high of Rs 86.88 during the session. The company\u2019s market capitalisation stood at Rs 4,614.87 crore, making this one-year high notable not just as a price milestone but also as a move in a mid-sized healthcare name that is trading above the sector\u2019s median market value.<\/p>\n<p>For readers tracking Morepen Laboratories Ltd. Share Price Today and Morepen Laboratories Ltd. Stock News, the verified data confirms a clear price event: the stock set a new 52-week peak with turnover of Rs 7.01 crore and traded in a session range between Rs 83.16 and Rs 86.88. The supplied data confirms the move, but it does not establish a company-specific catalyst behind the rise.<\/p>\n<p>That still leaves plenty for investors to assess. At Univest, the key questions around Morepen Laboratories Ltd. Share Price are whether the move is backed by strong trading participation, how current valuation compares with the broader Healthcare sector, and whether fundamental ratios support or challenge investor attention. This Univest analysis focuses on verified price action, valuation, profitability, sector benchmarks and peer positioning rather than speculation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Morepen_Laboratories_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Morepen Laboratories Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 85.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 84.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 1 (+1.19%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 84.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 86.88<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 83.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8,22,834<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7.01 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,614.87 crore<\/td>\n<\/tr>\n<\/table>\n<p>Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 85.22. versus the previous close of Rs 84.22, a rise of 1.19%. The stock opened at Rs 84.67, reached Rs 86.88, touched Rs 83.16. Reported volume was 8,22,834.<\/p>\n<p>Morepen Laboratories Ltd. Share Price Today reflects a confirmed breakout session in which the stock moved above its earlier one-year range and printed a fresh 52-week high of Rs 86.88. The stock opened at Rs 84.67, slipped to a day low of Rs 83.16, and then climbed to its 52-week peak before trading at Rs 85.22, still above the previous close of Rs 84.22.<\/p>\n<p>In absolute terms, the day change was Rs 1, or 1.19%. That may look moderate on a percentage basis, but the intraday range shows active price discovery. From the day low of Rs 83.16 to the day high of Rs 86.88, the spread was Rs 3.72, indicating that traders were willing to transact across a fairly wide band as the stock entered new one-year-high territory.<\/p>\n<p>Volume also matters when a stock joins the list of 52 Week High Stocks. Morepen Laboratories Ltd. recorded current volume of 8,22,834 shares, with turnover at Rs 7.01 crore. Those figures indicate visible market participation in the move and help explain why the stock is appearing in Morepen Laboratories Ltd. News Today, Stock Market Today screens and broader Stocks in News conversations.<\/p>\n<p>For investors following Morepen Laboratories Ltd. Share News and Morepen Laboratories Ltd. Share Price Live movements, the key fact is straightforward: the stock has reached a fresh yearly high, and price action has moved beyond prior one-year levels. The next step is to judge whether that market attention is supported by the company\u2019s current fundamental profile.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Morepen_Laboratories_Ltd_MOREPENLAB_Fundamental_Analysis\"><\/span><strong>Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,614.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">184.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Morepen Laboratories Ltd. was valued at a P\/E ratio of 184.72x, a P\/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">184.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,603.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.15%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,614.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 135.27 crore<\/td>\n<\/tr>\n<\/table>\n<p>Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare.<\/p>\n<p>Morepen Laboratories Ltd. (MOREPENLAB) has a P\/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,985.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">184.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,827.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">68.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,645.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,612.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,559.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">58.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<\/table>\n<p>Morepen Laboratories Ltd. (MOREPENLAB) has a P\/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 4,614.87 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Morepen_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Morepen Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock is attracting attention because a verified market event has combined with contrasting valuation and profitability signals. For anyone scanning Market News, Market Movers and Morepen Laboratories Ltd. Company News, these are the key monitored points from the supplied data.<\/p>\n<ul>\n<li>Morepen Laboratories Ltd. Share Price hit a fresh 52-week high of Rs 86.88 and was trading at Rs 85.22, up 1.19% on the day.<\/li>\n<li>The stock recorded current volume of 8,22,834 shares and turnover of Rs 7.01 crore during the move.<\/li>\n<li>Market capitalisation stands at Rs 4,614.87 crore, above the sector median of Rs 135.27 crore and average of Rs 456.49 crore.<\/li>\n<li>The P\/E Ratio of 184.72 is above the Healthcare sector median of 21.1 and average of 49.38.<\/li>\n<li>The P\/B Ratio of 0.45 is below the sector median of 1.9 and average of 2.3.<\/li>\n<li>ROE at -2.89 and ROCE at -0.26 are below the sector benchmark medians and averages.<\/li>\n<li>Peer comparison shows a larger market cap than the supplied peers, but weaker return ratios than several of them.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Morepen_Laboratories_Ltd\"><\/span><strong>About Morepen Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Morepen Laboratories Ltd. is presented in the supplied dataset as part of the Healthcare sector. In peer classification, the company is grouped alongside Pharmaceuticals &amp; Drugs names, which places it in a segment of the Indian stock market that is often tracked for valuation, profitability and sector-relative performance.<\/p>\n<p>Because the verified input for this article is primarily event and market data, the clearest company context available is its position within Healthcare and its comparison with listed peers such as Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories and Fredun Pharmaceuticals. That peer set matters because it frames how Morepen Laboratories Ltd. Share Price is being judged in the market today: not only as a stock reaching a 52-week high, but as a Healthcare company trading at a higher market capitalisation than the supplied comparables.<\/p>\n<p>For investors following Morepen Laboratories Ltd. Stock News and Morepen Laboratories Ltd. Earnings-related searches, the most relevant takeaway from the available company context is its placement inside a broad Healthcare benchmark of 201 companies, where size, valuation and returns currently paint a mixed but closely watched profile.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Morepen_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Morepen Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\">Morepen Laboratories Ltd. (MOREPENLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors using Univest can track Morepen Laboratories Ltd. Share Price through a single market view that brings together live share price moves, 52-week levels, valuation ratios, peer comparison and broader market insights. That makes it easier to follow whether the stock remains near its one-year high and how it is positioned versus sector benchmarks.<\/p>\n<p>Univest also helps readers monitor Morepen Laboratories Ltd. Share Price Today alongside market capitalisation, P\/E Ratio, P\/B Ratio, ROE, ROCE and comparative Healthcare data. For users scanning Share Market Today screens, this kind of side-by-side context is useful because the stock\u2019s fresh 52-week peak comes with a valuation profile and return profile that do not point in the same direction.<\/p>\n<p>As Morepen Laboratories Ltd. Stock News develops, Univest readers can continue to monitor price action, stock performance, sector context and peer metrics in one place without relying on speculation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Morepen_Laboratories_Ltd_Share_Price\"><\/span><strong>What is the current Morepen Laboratories Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Morepen Laboratories Ltd. Share Price was Rs 85.22 at the time of this update. The stock was up Rs 1, or 1.19%, from the previous close of Rs 84.22 after touching a fresh 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Morepen_Laboratories_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Morepen Laboratories Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock is in focus because it hit a fresh 52-week high of Rs 86.88 during the session. It also traded with volume of 8,22,834 shares and turnover of Rs 7.01 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_fresh_52-week_high_for_Morepen_Laboratories_Ltd\"><\/span><strong>What was the fresh 52-week high for Morepen Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Morepen Laboratories Ltd. recorded a fresh 52-week high of Rs 86.88. The stock later traded at Rs 85.22, which still kept it above the previous close of Rs 84.22 in the same session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Morepen_Laboratories_Ltd_gain_today\"><\/span><strong>How much did Morepen Laboratories Ltd. gain today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock gained Rs 1 on the day, which translates into a rise of 1.19%. It opened at Rs 84.67, moved between Rs 83.16 and Rs 86.88, and stayed positive versus the previous close.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Morepen_Laboratories_Ltd\"><\/span><strong>What does today\u2019s price action show for Morepen Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Today\u2019s price action shows the stock opening at Rs 84.67, dipping to Rs 83.16, and then climbing to a fresh one-year high of Rs 86.88. That intraday move highlights active participation around new highs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Morepen_Laboratories_Ltd\"><\/span><strong>What is the market capitalisation of Morepen Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Morepen Laboratories Ltd. had a market capitalisation of Rs 4,614.87 crore in the supplied data. That is above the Healthcare sector median of Rs 135.27 crore and average of Rs 456.49 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Morepen_Laboratories_Ltd_expensive_compared_with_the_Healthcare_sector_on_PE\"><\/span><strong>Is Morepen Laboratories Ltd. expensive compared with the Healthcare sector on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E Ratio is 184.72, while the supplied Healthcare sector median is 21.1 and the average is 49.38. On that benchmark, the stock is trading above both the median and average sector multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Morepen_Laboratories_Ltd_compare_on_price-to-book_value\"><\/span><strong>How does Morepen Laboratories Ltd. compare on price-to-book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Morepen Laboratories Ltd. has a P\/B Ratio of 0.45. That is below the supplied Healthcare sector median of 1.9 and average of 2.3, showing a lower price-to-book valuation than those benchmark levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_indicate_for_Morepen_Laboratories_Ltd\"><\/span><strong>What do ROE and ROCE indicate for Morepen Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied profitability ratios show ROE at -2.89 and ROCE at -0.26. Both are below the Healthcare sector medians of 10.71 and 13.15, and also below the sector averages of 14.5 and 16.94.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Morepen_Laboratories_Ltd_compare_with_its_peers\"><\/span><strong>How does Morepen Laboratories Ltd. compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Morepen Laboratories Ltd. has a higher market cap at Rs 4,614.87 crore than the supplied peers, but its ROE of -2.89 and ROCE of -0.26 trail several peers including Beta Drugs and Fredun Pharmaceuticals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Morepen Laboratories Ltd. Share Price hits a new 52-week high at Rs 85.22. marking a 1.19% rise today. Market cap stands at Rs 4,614.87 crore.<\/p>\n","protected":false},"author":29,"featured_media":205872,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-205873","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["205872"],"rank_math_title":["Morepen Laboratories Ltd. Share Price at Fresh 52-Week High"],"rank_math_description":["Morepen Laboratories Ltd. Share Price hit a fresh 52-week high at Rs 86.88. Track price action, valuation, sector benchmarks and peer analysis."],"rank_math_focus_keyword":["Morepen Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Morepen_Laboratories_Ltd_MOREPENLAB_Share_Price_Hits_Fresh_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=205873"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205873\/revisions"}],"predecessor-version":[{"id":205875,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205873\/revisions\/205875"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/205872"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=205873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=205873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=205873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}